Impacts and Pathways of Behavioral Activation on Psychological Distress Among Patients Diagnosed With Esophageal and Gastric Cancer in China: A Randomized Controlled Trial
Cancer Medicine · 2024
DOI: 10.1002/cam4.70314 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cancer Medicine, 2024. Verfasst von Runze Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Esophageal Neoplasms, Self Efficacy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The objective of this study is to investigate the efficacy of behavioral activation (BA), a novel psychological intervention, in ameliorating psychological distress and anxiety symptoms among patients diagnosed with esophageal and gastric cancer, as well as the mediating role of self‐efficacy between BA and psychological distress.
Methods
A total of 139 patients diagnosed with esophageal and gastric cancer were recruited in China from March 2023 to October 2023 and randomly assigned to either the BA plus care as usual group (BA+CAU group) or the care as usual group (CAU group). Pre‐ and post‐intervention questionnaires, including the Psychological Distress Thermometer (DT), Generalized anxiety disorder 7‐item (GAD‐7) Scale, General Self‐Efficacy Scale (GSES) and the activation subscale of Behavioral Activation for Depression Scale (BADS‐A), were administered.
Results
Generalized estimating equation analyses revealed that, compared to usual care alone, combining BA with usual care significantly ameliorated psychological distress, anxiety as well as improved self‐efficacy and activation. The mediation analysis revealed that self‐efficacy served as a mediator in the relationship between activation and psychological distress.
Conclusions
BA primarily based on telephone or WeChat can not only directly ameliorates psychological distress and anxiety symptoms in patients with esophageal cancer and gastric cancer but also indirectly alleviates psychological distress by enhancing self‐efficacy. The study also demonstrates the potential of BA in cancer patients, a skill that can be effectively acquired by primary care workers without specialized training and implemented more flexible. Trial Registration: NCT06348940
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- Anhui Medical University, Hefei, Anhui, China.
- School of Nursing, Anhui Medical University, Hefei, Anhui, China.
- Medical Intensive Care Unit, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.
- The Third School of Clinical Medicine, Southern Medical University, Guangzhou, People's Republic of China.
- Department of Oncology, Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, China.
ORCID-Profile: Runze Huang, Huaidong Cheng
Zitieren
APA
Huang, R., Li, A., Ge, H., Liu, L., Cheng, L., Zhang, M., & Cheng, H. (2024). Impacts and Pathways of Behavioral Activation on Psychological Distress Among Patients Diagnosed With Esophageal and Gastric Cancer in China: A Randomized Controlled Trial. Cancer Medicine. https://doi.org/10.1002/cam4.70314
Vancouver
Huang R, Li A, Ge H, Liu L, Cheng L, Zhang M, et al. Impacts and Pathways of Behavioral Activation on Psychological Distress Among Patients Diagnosed With Esophageal and Gastric Cancer in China: A Randomized Controlled Trial. Cancer Medicine. 2024. doi:10.1002/cam4.70314
BibTeX
@article{Huang2024,
author = {Huang, Runze and Li, Anlong and Ge, Han and Liu, Lijun and Cheng, Ling and Zhang, Mingjun and Cheng, Huaidong},
title = {Impacts and Pathways of Behavioral Activation on Psychological Distress Among Patients Diagnosed With Esophageal and Gastric Cancer in China: A Randomized Controlled Trial},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70314}
}
EUVIMED